INTEREST

Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial

Communications

Oral communication presented at the 9th INTEREST Workshop in Harare the 7th of May 2015 in session Round table: Treatment as Prevention (TaSP) studies.

Dr Joseph Larmarange from on Vimeo.

Reference

Larmarange Joseph (2015) “Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial” (communication orale), presented at the 9th INTEREST Workshop, Harare. http://www.virology-education.com/online-program-9th-interest/.

2002-2024 — Joseph Larmarange
Contact et Mentions légales | Catégories | Crédits